TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
AUTL

Autolus Therapeutics plc

Healthcare · Biotechnology

1.90$ +0.3% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement AUTL
Line item 2015 2016 2017 2018 2018 2019 2020 2021 2022 2023 2024 2025
– +1,187.8% +39.7% -38.3% +0.0% +178.2% -41.0% -12.1% +311.0% -72.6% +496.0% +646.7%
– – +111.1% +4,686.8% +0.0% +118.3% +28.0% -4.6% +6.7% -95.2% +2,048.1% -31.5%
– +679.9% -6.8% -7,008.4% – – – – +311.0% -72.6% -7,809.1% –
– +380.3% +53.4% +53.9% +0.0% +328.7% +27.8% -17.9% +5.9% +11.2% +21.2% -18.7%
– -14.8% +76.6% +85.1% +0.0% +134.2% -11.4% -8.9% +0.1% +46.5% +116.2% +30.5%
– +90.1% +61.1% +65.2% +0.0% +249.7% +17.2% -16.5% +5.1% +21.7% -39.1% +135.6%
– – – – – – – – – – – –
– – -22.4% -66.7% +0.0% +8,962.9% +64.5% -41.5% +705.9% +406.1% -79.4% +295.5%
– – – – – – – – – – – –
– – – – – – -259.4% – +369.0% -107.0% – -666.0%
– – – – – – – – – – – –
– – – – – – – – – – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?